Trending

Featured

April 11, 2024

AIROS Medical Names Darren Behuniak as Chief Operating Officer

AUDUBON, Pa.--(BUSINESS WIRE)--AIROS Medical, Inc., a medical technology manufacturer and designer specializing in... Read more »

April 10, 2024

Lynn Bruder Acquires Nucleus Healthcare

Nucleus Healthcare, a premier staffing and recruitment agency based in Philadelphia has become a woman-owned... Read more »

April 9, 2024

TEDCO-backed Astek Diagnostics Closes Strategic Funding Round

Astek Diagnostics has closed on a strategic funding round led by She’s Independent, an angel investing group based in... Read more »

citybiz
Gain exposure through our multi-channel news platform.
For AgenciesFor Enterprise
April 17, 2024

NRx Pharmaceuticals Announces New Data on NRX-101 Demonstrating No Damage to Intestinal and Vaginal Flora in Validated Rodent Models Compared to Standard Antibiotics

April 17, 2024

NRx Pharmaceuticals Announces Proposed Underwritten Public Offering of Common Stock

April 17, 2024

Lipella Pharmaceuticals Expands its Advisory Board

April 17, 2024

The Children’s Place Announces $90 Million Financing Provided by Majority Shareholder Mithaq Capital

April 16, 2024

Evergreen Theragnostics Completes $26M Capital Raise

April 16, 2024

Health Advocate Partners with Tava Health

April 15, 2024

A Biotech Hub is Rising at Philadelphia’s Shuttered Hahnemann Hospital Campus

April 15, 2024

NRx Pharmaceuticals Announces Development of New, Proprietary Formulation of HTX-100

April 9, 2024

Clare Medical and Ennoble Care’s New Jersey Housecall Practices to Merge

April 9, 2024

SC&H Capital Advises Humanigen in Sale to Taran Therapeutics

April 9, 2024

AscellaHealth Recognized by The Financial Times for Three Consecutive Years as One of “Americas’ Fastest Growing Companies”

April 9, 2024

2024’s Best & Worst States for Children’s Health Care – WalletHub Study

April 8, 2024

NRx Pharmaceuticals Announces Data-Lock of Phase 2b/3 Trial of NRX-101 in Suicidal Treatment Resistant Bipolar Depression

April 8, 2024

Cleveland Clinic’s Dr. Matt Kalaycio Appointed Chair of Board of Directors for National Comprehensive Cancer Network

April 8, 2024

Alterome Therapeutics Raises $132M in Series B

April 8, 2024

TELA Bio Appoints Howard N. Langstein, MD, FACS, as Vice President of Medical Affairs and Surgeon Strategy